Treating Temporomandibular Joint Syndrome in Arthrogenous TMD — When Neuromodulatory Agents Are Not Appropriate

This protocol addresses temporomandibular joint syndrome arising from an arthrogenous subtype of temporomandibular disorder (TMD) — a structural, joint-based form of the condition — including presentations such as disc displacement without reduction with specific case features.

Clinical Scenario

The patient presents with arthrogenous temporomandibular disorder. In this subtype, the underlying pathology is joint-structural in nature rather than muscular or psychosocial.

Neuromodulatory agents have not been shown to be beneficial for arthrogenous TMD sub-diagnoses and their use in such situations is not advocated.

Treatment Approach (Partial Overview)

For severe arthrogenous TMD, the structured protocol includes consideration of surgical intervention — applied as an adjunct to conservative and supportive measures, and not as a standalone or first-line option. The full protocol specifies which case features and presentations meet the threshold for this step.

Full regimen, sequencing, and case selection criteria available via the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

Neuromodulatory agents have not been shown to be beneficial for arthrogenous TMD sub diagnoses and their use in such situations is not advocated.
There are two situations where surgical intervention may be appropriate, severe arthrogenous TMD and disc displacement without reduction with specific case features (see Table 7 and Figure 3).
Where surgical management is advocated, it should be provided as an adjunct to SSM and conservative treatment strategies and not as a sole or first line option.

View source ↗